vs

Side-by-side financial comparison of AbbVie (ABBV) and Chubb Limited (CB). Click either name above to swap in a different company.

Chubb Limited is the larger business by last-quarter revenue ($15.1B vs $15.0B, roughly 1.0× AbbVie). Chubb Limited runs the higher net margin — 21.3% vs 4.6%, a 16.7% gap on every dollar of revenue. On growth, AbbVie posted the faster year-over-year revenue change (9.9% vs 6.3%). Over the past eight quarters, Chubb Limited's revenue compounded faster (8.1% CAGR vs 1.8%).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Chubb Limited is an American–Swiss company incorporated in Zürich, and listed on the New York Stock Exchange (NYSE) where it is a component of the S&P 500. Chubb is a global provider of insurance products covering property and casualty, accident and health, reinsurance, and life insurance and is the largest publicly traded property and casualty insurance company in the world. Chubb operates in 55 countries and territories and in the Lloyd's insurance market in London. Clients of Chubb consist...

ABBV vs CB — Head-to-Head

Bigger by revenue
CB
CB
1.0× larger
CB
$15.1B
$15.0B
ABBV
Growing faster (revenue YoY)
ABBV
ABBV
+3.6% gap
ABBV
9.9%
6.3%
CB
Higher net margin
CB
CB
16.7% more per $
CB
21.3%
4.6%
ABBV
Faster 2-yr revenue CAGR
CB
CB
Annualised
CB
8.1%
1.8%
ABBV

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ABBV
ABBV
CB
CB
Revenue
$15.0B
$15.1B
Net Profit
$697.0M
$3.2B
Gross Margin
Operating Margin
26.6%
25.0%
Net Margin
4.6%
21.3%
Revenue YoY
9.9%
6.3%
Net Profit YoY
-45.9%
24.7%
EPS (diluted)
$0.39
$8.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABBV
ABBV
CB
CB
Q1 26
$15.0B
Q4 25
$16.6B
$15.1B
Q3 25
$15.8B
$16.1B
Q2 25
$15.4B
$14.8B
Q1 25
$13.3B
$13.4B
Q4 24
$15.1B
$14.2B
Q3 24
$14.5B
$14.8B
Q2 24
$14.5B
$13.8B
Net Profit
ABBV
ABBV
CB
CB
Q1 26
$697.0M
Q4 25
$1.8B
$3.2B
Q3 25
$186.0M
$2.8B
Q2 25
$938.0M
$3.0B
Q1 25
$1.3B
$1.3B
Q4 24
$-22.0M
$2.6B
Q3 24
$1.6B
$2.3B
Q2 24
$1.4B
$2.2B
Gross Margin
ABBV
ABBV
CB
CB
Q1 26
Q4 25
72.6%
Q3 25
66.4%
Q2 25
71.8%
Q1 25
70.0%
Q4 24
70.9%
Q3 24
70.9%
Q2 24
70.9%
Operating Margin
ABBV
ABBV
CB
CB
Q1 26
26.6%
Q4 25
27.3%
25.0%
Q3 25
12.1%
24.1%
Q2 25
31.7%
25.0%
Q1 25
28.0%
12.5%
Q4 24
-9.9%
22.0%
Q3 24
26.5%
20.2%
Q2 24
27.6%
19.6%
Net Margin
ABBV
ABBV
CB
CB
Q1 26
4.6%
Q4 25
10.9%
21.3%
Q3 25
1.2%
17.3%
Q2 25
6.1%
20.0%
Q1 25
9.6%
10.0%
Q4 24
-0.1%
18.2%
Q3 24
10.8%
15.7%
Q2 24
9.5%
16.1%
EPS (diluted)
ABBV
ABBV
CB
CB
Q1 26
$0.39
Q4 25
$1.02
$8.05
Q3 25
$0.10
$6.99
Q2 25
$0.52
$7.35
Q1 25
$0.72
$3.29
Q4 24
$-0.03
$6.31
Q3 24
$0.88
$5.70
Q2 24
$0.77
$5.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABBV
ABBV
CB
CB
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$15.7B
Stockholders' EquityBook value
$73.8B
Total Assets
$272.3B
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABBV
ABBV
CB
CB
Q1 26
Q4 25
$5.3B
Q3 25
$5.7B
Q2 25
$6.5B
Q1 25
$5.2B
Q4 24
$5.6B
Q3 24
$7.3B
Q2 24
$13.2B
Total Debt
ABBV
ABBV
CB
CB
Q1 26
Q4 25
$58.9B
$15.7B
Q3 25
$63.0B
$15.7B
Q2 25
$63.0B
$13.5B
Q1 25
$64.5B
$14.5B
Q4 24
$60.3B
$14.4B
Q3 24
$58.5B
$14.6B
Q2 24
$58.0B
$13.2B
Stockholders' Equity
ABBV
ABBV
CB
CB
Q1 26
Q4 25
$-3.3B
$73.8B
Q3 25
$-2.6B
$71.9B
Q2 25
$-183.0M
$69.4B
Q1 25
$1.4B
$65.7B
Q4 24
$3.3B
$64.0B
Q3 24
$6.0B
$65.8B
Q2 24
$6.8B
$61.0B
Total Assets
ABBV
ABBV
CB
CB
Q1 26
Q4 25
$134.0B
$272.3B
Q3 25
$133.9B
$270.2B
Q2 25
$137.2B
$261.6B
Q1 25
$136.2B
$251.8B
Q4 24
$135.2B
$246.5B
Q3 24
$143.4B
$250.6B
Q2 24
$141.9B
$238.6B
Debt / Equity
ABBV
ABBV
CB
CB
Q1 26
Q4 25
0.21×
Q3 25
0.22×
Q2 25
0.19×
Q1 25
45.44×
0.22×
Q4 24
18.15×
0.22×
Q3 24
9.70×
0.22×
Q2 24
8.56×
0.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABBV
ABBV
CB
CB
Operating Cash FlowLast quarter
$4.1B
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.26×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABBV
ABBV
CB
CB
Q1 26
Q4 25
$5.2B
$4.1B
Q3 25
$7.0B
$3.6B
Q2 25
$5.2B
$3.6B
Q1 25
$1.6B
$1.6B
Q4 24
$7.0B
$4.6B
Q3 24
$5.4B
$4.3B
Q2 24
$2.3B
$4.1B
Free Cash Flow
ABBV
ABBV
CB
CB
Q1 26
Q4 25
$4.9B
Q3 25
$6.6B
Q2 25
$4.9B
Q1 25
$1.4B
Q4 24
$6.8B
Q3 24
$5.2B
Q2 24
$2.0B
FCF Margin
ABBV
ABBV
CB
CB
Q1 26
Q4 25
29.4%
Q3 25
42.1%
Q2 25
31.7%
Q1 25
10.5%
Q4 24
44.7%
Q3 24
35.9%
Q2 24
14.0%
Capex Intensity
ABBV
ABBV
CB
CB
Q1 26
Q4 25
2.0%
Q3 25
2.4%
Q2 25
1.7%
Q1 25
1.8%
Q4 24
1.9%
Q3 24
1.7%
Q2 24
1.7%
Cash Conversion
ABBV
ABBV
CB
CB
Q1 26
Q4 25
2.87×
1.26×
Q3 25
37.76×
1.30×
Q2 25
5.49×
1.20×
Q1 25
1.27×
1.18×
Q4 24
1.77×
Q3 24
3.49×
1.86×
Q2 24
1.66×
1.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons